Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Cepharanthine can block enterovirus entry and protect against infection.

Icariside II may help treat gastric cancer by stopping tumor growth.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

The new drug delivery system effectively targets lung cancer cells.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

The treatment combination is effective and generally safe for lung cancer.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Pantethine may boost the immune system's ability to fight sarcoma.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Some drugs for inflammation may cause psoriasis-like hair loss.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Deucravacitinib may effectively treat discoid lupus erythematosus.